HOME >> BIOLOGY >> NEWS
Success rates for prostate cancer depend on experience of surgeon

Surgeons performing operations to remove patients prostate glandsthe primary treatment for prostate cancergo through a steep learning curve, according to a study published online July 24 in the Journal of the National Cancer Institute. As the surgeons gain more experience performing the operation, called a radical prostatectomy, the chance that patients prostate cancer will reoccur goes down.

The idea that more experienced surgeons perform more successful surgeries is a widely held belief. But there have been few data to support this idea, and it has not been previously shown whether a surgeons experience makes a large or small difference on their patients outcome.

Andrew Vickers, Ph.D., of Memorial Sloan-Kettering Cancer Center in New York and colleagues analyzed data from 72 surgeons at four institutions and 7,765 of their prostate cancer patients treated with radical prostatectomies between 1987 and 2003. They measured surgeons experience by the number of times they had performed the procedure before each operation.

More surgical experience was associated with a greater likelihood that the patients cancer would not return after their operation. The learning curve for this procedure was very steepthere was dramatic improvement in patient outcomes as surgeons experience increased up to 250 operations, after which increasing experience had little influence on cancer recurrence. Patients treated by inexperienced surgeons (for example, those with 10 prior operations) were nearly 70% more likely to have evidence of recurrence of their prostate cancer within five years than those whose surgeons had performed 250 operations (17.9% vs. 10.7%).

Our findings also have implications for education in surgical oncology. Although the successful practice of surgery necessarily presumes a lifetime of learning, the large number of cases required before the learning curve plateaus suggests the need to expand opportunities for trai
'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
24-Jul-2007


Page: 1 2

Related biology news :

1. Success or failure of antidepressant citalopram predicted by gene variation
2. Successful development of prototype assays
3. Successful lung cancer surgery not enough to break nicotine dependence in many smokers
4. Successful one year gene therapy trial for Parkinsons disease announced by Neurologix
5. Successful transplantation from pig embryos to mice
6. Success comes at a cost, even for phages
7. Successful cell engineering may lead to mad cow prevention, say researchers
8. Success tastes sweet for scientists
9. Successful test of single molecule switch opens the door to biomolecular electronics
10. New study demonstrates important role of glia in circadian timing
11. High rates of HIV infection documented among young Nepalese girls sex-trafficked to India

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Success rates for prostate cancer depend experience surgeon

(Date:5/16/2013)... predict the stability of today,s largest ice sheets in Greenland ... years ago, for example when Earth was going through ... a high sea level due to ice sheet collapse at ... that if the world,s largest ice sheets collapsed in the ... modern, progressively warming world. , However, a new groundbreaking ...
(Date:5/16/2013)... cellular layer lining the body,s blood vessels, is ... in thickness, this super-tenuous structure routinely withstands blood ... create a unique and highly dynamic barrier that ... the body,s circulatory system. , It,s also extremely ... physically breached to enable immune cells to ...
(Date:5/16/2013)... 16, 2013 Integrated Biometrics patented LES ... custom thin film transistor camera introduces Sherlock, a ... image in the smallest and lightest form factor ... F Mobile ID FAP 45, Certified scanner is ... size and weight when compared to optical scanners. ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
(Date:5/16/2013)... (PRWEB) May 16, 2013 ... Barbara A. Myers, CAE, to the newly created ... her new role, Myers will be responsible for ... and production strategies, advancing the Society’s Member-led and ... and continuing to refine organizational, membership and product ...
(Date:5/16/2013)... 16, 2013 Cambridge Healthtech Institute will ... 19-23, 2013 at the Renaissance Waterfront Hotel in Boston, ... a close-up look at the current strategies and innovations ... quality. Leaders in the field will reveal how ... biopharmaceuticals with greater specificity and efficiency. , “In this ...
(Date:5/16/2013)... -- Scientists at the Center for Learning and Memory, ... California -based biopharmaceutical company Magceutics, Inc. ... reversing memory decline in mice with Alzheimer,s Disease. By ... in advanced stage AD mice. The study is the ... for advanced stage AD mice, and is also the ...
(Date:5/16/2013)... NEW YORK , May 16, ... a new market research report is ... MediPoint: Diagnostic Cardiac Biomarkers for ... and Market Forecasts ... Cardiac Biomarkers for Acute Coronary Syndromes ...
Breaking Biology Technology:ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8
Cached News: